Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-14

Clinical Trial Update: Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tapentadol hydrochloride for severe osteoarthritis pain in patients on WHO Step III analgesics who have poor tolerability; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Chronic Pain, Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2011-12-14